Applied DNA Sciences
ADNAS | Crime fighting has never had a weapon like this.
Launch date
Employees
Market cap
€14.1m
Enterprise valuation
€5m (Public information from Sep 2024)
Share price
$1.32 APDN
Town of Brookhaven New York (HQ)
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | 5.4m | 1.9m | 9.0m | 18.2m | 13.4m | 3.5m | 5.2m |
% growth | 38 % | (64 %) | 367 % | 101 % | (26 %) | (74 %) | 48 % |
EBITDA | (8.1m) | (12.6m) | (9.7m) | (21.4m) | (10.4m) | - | - |
% EBITDA margin | (150 %) | (654 %) | (107 %) | (118 %) | (78 %) | - | - |
Profit | (8.6m) | (13.0m) | (14.3m) | (8.3m) | (9.9m) | - | - |
% profit margin | (160 %) | (674 %) | (158 %) | (46 %) | (74 %) | - | - |
R&D budget | 3.0m | 3.3m | 3.8m | 3.9m | 3.7m | - | - |
R&D % of revenue | 55 % | 172 % | 42 % | 22 % | 28 % | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
N/A | $450k | Post IPO Equity | |
N/A | $5.0m | Post IPO Equity | |
N/A | $1.5m | Post IPO Equity | |
$150k | Grant | ||
N/A | $7.5m | Post IPO Equity | |
$975k | Grant | ||
N/A | $2.1m | Post IPO Equity | |
N/A | $1.8m | Post IPO Debt | |
N/A | $1.8m | Post IPO Equity | |
N/A | $12.0m | Post IPO Equity | |
N/A | $15.0m | Post IPO Equity | |
N/A | $4.2m | Post IPO Equity | |
* | N/A | $12.0m | Post IPO Equity |
* | $1.5m | Grant | |
* | N/A | $3.4m | Post IPO Equity |
* | N/A | $12.0m | Post IPO Equity |
Total Funding | €2.4m |
Recent News about Applied DNA Sciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Applied DNA Sciences
EditACQUISITION by Applied DNA Sciences Sep 2015
ACQUISITION by Applied DNA Sciences Jul 2023